Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* pediatric patients age 2 to 17 years old~* have a laceration of 4 cm on the face or 7 cm on the remainder of the body~* Require procedural sedation to repair the laceration~Exclusion Criteria:~* Patients with abnormal nasal physiology which would not allow for adequate medication delivery~* Unable to have a guardian present to consent on their behalf~* Allergy to ketamine~* Significant cardiac history (myocardial ischemia, heart failure, arrhythmias)~* Presenting with a head injury associated with possible intracranial hypertension~* Pregnancy~* Lacerations that require repair from a consult service

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- Intranasal Ketamine (Type: EXPERIMENTAL): None
- Intramuscular Ketamine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).